About Carl McKinzie
Carl McKinzie is a member of the board at Athos Therapeutics.
Form D filings also name Carl McKinzie as a director at Trethera.
Carl McKinzie first appears on SEC filings in 2015.
Experience
This experience comes from Carl McKinzie's profile and from SEC filings. For roles taken from filings, the years are when the filings name Carl McKinzie in the role, so the role may have started earlier or lasted longer.
Athos Therapeutics, Inc. Current
Member of the Board
2019 – Present · Torrance, CA
Develops AI-assisted medicines for people with autoimmune and inflammatory diseases.
Trethera Corp Current
Director & Corporate Secretary (previously President & CEO) (2014 – Present)
Director
2014 – Present · Sherman Oaks, CA
SF
Saint John's Health Center Foundation Current
Trustee
2004 – Present
PC
Providence Saint John's Health Center Current
Senior Advisor and former Board Chair and Director
2001 – Present
TF
The Riordan Foundation Current
Trustee
1992 – Present
BF
Broadcom Foundation
Director, Chair of Audit Committee
2016 – 2025
SB
Sofie Biosciences
Director
2014 – 2024
WI
Welk Hospitality Group, Inc.
Director
2004 – 2021
FC
FirstFed Financial Corp.
CEO
2010 – 2013
CE
Carl W. McKinzie, Esq.
Attorney
Key Colleagues at Startups
The people Carl McKinzie works with at each company, as listed on that company's latest Form D.
Athos Therapeutics, Inc. · Form D, May 15, 2026
LS
Laurence Stein
Member of the Board
JC
Joel Cohen
Member of the Board
AZ
Anthony Zingale
Director
Dimitrios Iliopoulos
President & CEO, director
AP
Allan Pantuck
Chairman & CMO
Trethera Corp · Form D, May 2, 2025
LG
Louis Gonda
Director
KD
Kenneth Schultz, M.D.
CEO and director
LD
Laurent Dubois
Director
TD
Timothy Donahue, M.D.
Director
RQ
R. Quinnell
Director